Please Login to read the full article.
Clinica
US FDA consults on fulfilling obligations for device post-market surveillance studies
18 August 2011
Vibha Sharma
Please Login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Call for delay as concerns continue over CMC labelling decision on manufacturer details
- US FDA explains processes to appeal against decisions of its device staff
- US FDA may be calling for increasingly demanding study device designs, signals draft guidance
- Howe report finds EU medtech adverse incident reporting fails on safety: registries needed
Other Informa News
EVENTS
